| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |